ClinicalTrials.Veeva

Menu

Cortical Excitability Using Transcranial Magnetic Stimulation and Neuronavigation Device (RC-TMS)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Completed

Conditions

Healthy Volunteers

Treatments

Device: TMS "Magpro®, Magventure Inc" device

Study type

Interventional

Funder types

Other

Identifiers

NCT02596789
2012-A00316-37

Details and patient eligibility

About

This study has two main goals :

  • to investigate the impact of aging on cortical excitability (CE)
  • to investigate the impact of "state dependency" on CE, using a cognitive task and an emotional one.

A Neuronavigation system of transcranial magnetic stimulation is used, and electromyographic response are recorded.

Enrollment

75 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • male or female
  • age 18-75
  • signed informed consent
  • normal physical examination

Exclusion criteria

  • less 18 or more 75 years of age
  • contra indication to TMS: epilepsia or seizures, metallic head devices, cardiac pacemaker, pregnancy, jet lag or severe insomnia the night before
  • severe physical disease
  • treatment with psychotropic drugs
  • overt psychiatric disease
  • alcohol consumption before the examination

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

75 participants in 1 patient group

state dependency TMS
Other group
Description:
TMS performed at rest and during a cognitive/emotional task
Treatment:
Device: TMS "Magpro®, Magventure Inc" device

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems